Zhejiang Ausun Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 577.91 million compared to CNY 429.68 million a year ago. Revenue was CNY 577.91 million compared to CNY 429.68 million a year ago.

Net income was CNY 177.08 million compared to CNY 110.31 million a year ago. Basic earnings per share from continuing operations was CNY 0.3143 compared to CNY 0.1929 a year ago. Diluted earnings per share from continuing operations was CNY 0.3143 compared to CNY 0.1929 a year ago.